Pretreatment serum LDH as additional staging parameter in small-cell lung carcinoma

Netherlands Journal of Medicine

Volumn 52, Issue 2, 1998, Pages 65-70

  Stokkel, M P M ^a   Van Eck Smit, B L F ^a   Zwinderman, A H ^a   Willems, L N A ^a   Pauwels, E K J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Lactate dehydrogenase; Limited disease; Occult metastasis; Small cell lung cancer

Indexed keywords

LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC IMAGING; FEMALE; HIGH RISK POPULATION; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OCCULT CANCER; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR GROWTH; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; L-LACTATE DEHYDROGENASE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0031978663     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(97)00080-6     Document Type: Article

References (24)

1. Smith I.E., Perren T.J., Ashley S.A.et al. Carboplatin, etoposide and ifosfamide as intensive chemotherapy for small-cell lung cancer. J. Clin. Oncol. 8:1990;899-905.
2. Elias A.D. Dose-intensive therapy for small cell lung cancer. Chest. 107:1995;261S-266S.
3. Feld R., Deboer G., Sagman U. Prognostic factors for small cell carcinoma of the lung. Eur. J. Cancer Clin. Oncol. 24:1988;353-355.
4. Dearing M.P., Steinberg S.M., Phelps R.et al. Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years. J. Clin. Oncol. 8:1990;1042-1049.
5. Healy E.A., Abner A. Thoracic and cranial radiotherapy for limited stage small cell lung cancer. Chest. 107:1995;249S-254S.
6. Albain K.S., Crowley J.J., LeBlanc M., Livingston R.B. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2580-Patient Southwest Oncology Group data base. J. Clin. Oncol. 8:1990;1563-1574.
7. Lassen U., Oesterlind K., Hansen M., Dombernowsky P., Bergman B., Hansen H.H. Long term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years - an analysis of 1714 consecutive patients. J. Clin. Oncol. 13:1995;1215-1220.
8. McCracken J.D., Janaki L.M., Crowley J.J.et al. Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study. J. Clin. Oncol. 8:1990;892-898.
9. Spiegelman D., Maurer L.H., Ware J.H.et al. Prognostic factors in small-cell carcinoma of the lung: an analysis of 1521 patients. J. Clin. Oncol. 7:1989;344-354.
10. Minna JD, Higgins GA, Glatstein EI. Cancer of the lung. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer, principles and practice of oncology. Philadelphia, PA: Lippincott, 1985;507-598.
11. Troell R.J., Terris D.J. Detection of metastases from head and neck cancers. Laryngoscope. 105:1995;247-250.
12. Beck P.R., Belfield A., Spoomer R.J., Blumgart L.H., Wood C.B. Serum enzymes in colorectal cancer. Cancer. 43:1979;1772-1776.
13. Sagman U., Feld R., Evans W.K., Warr D., Shepherd F.A., Payne D.et al. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer. J. Clin. Oncol. 9:1991;954-961.
14. Vezzoni M.A., Lucchini R., Giardini R.et al. Lactate dehydrogenase levels in cellular extracts of human malignant lymphomas. Tumori. 69:1983;279-282.
15. Shepherd F.A., Ginsberg R.J., Haddad R.et al. Importance of clinical staging in limited small cell lung cancer: a valuable system to separate prognostic subgroups. J. Clin. Oncol. 11:1993;1592-1597.
16. Oesterlind K., Andersen P.K. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res. 46:1986;4189-4194.
17. Cerney T., Blair V., Anderson H., Bramwell H., Thatcher N. Pretreatment prognostic factors and scoring system in 407 small cell lung cancer patients. Int. J. Cancer. 39:1987;146-149.
18. Onoshi T., Hiraki S., Nakata Y.et al. Pretreatment serum albumin concentration and lactic dehydrogenase activity as prognostic factors in patients with small cell lung cancer. Acta Med. Okayama. 36:1982;487-490.
19. Vincent M.D., Ashley S.E., Smith I.E. Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging. Eur. J. Cancer Clin. Oncol. 23:1987;1589-1599.
20. Wang T., Feld R., Sagman U.et al. The combined use of LDH and CEA as independent prognostic markers for small cell lung cancer. Proc. Am. Assoc. Cancer Res. 27:1986;162.
21. Abrams J., Doyle L.A., Aisner J. Staging, prognostic factors and special considerations in small cell lung cancer. Semin. Oncol. 15:1988;261-277.
22. Ihde D.C., Makuch R.Q., Carney D.N.et al. Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am. Rev. Respir. Dis. 123:1981;500-507.
23. Sepherd F.A., Evans W.K., Feld R.et al. Adjuvant chemotherapy following surgical resection for small cell carcinoma of the lung. J. Clin. Oncol. 6:1988;832-838.
24. Sagman U., Maki E., Evans W.K.et al. Small-cell carcinoma of the lung: derivation of a prognostic staging system. J. Clin. Oncol. 9:1991;1639-1649.